Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Provider Notice issued 09/10/12

Enrollment in the 340B Program

To​ Participating Medical Assistance Providers​
​Date: ​September 10, 2012
​Re: Enrollment in the 340B Program​

As a result of Public Act 097-0689 (pdf), referred to as the Save Medicaid Access and Resources Together (SMART) Act, HFS will require all 340B eligible providers as defined in Section 340B of the federal Public Health Services Act to be enrolled as a 340B provider with the US Department of Health and Human Services (DHHS).

Pharmacy Providers

Effective October 1, 2012, an HFS enrolled pharmacy that is eligible to participate in the 340B federal Drug Pricing Program as defined in Section 340B of the federal Public Health Services Act shall enroll in that program. No HFS enrolled pharmacy that is also enrolled with DHHS as a 340B provider may exclude Medicaid covered medications from their participation in the program. An HFS enrolled pharmacy that is also enrolled in the 340B federal Drug Pricing Program must charge the department no more than their actual acquisition cost for the drug product plus the department established dispensing fee of $5.50 for generic drugs and $2.40 for brand name drugs. A 340B pharmacy billing the department for blood factor may charge the department actual shipping costs in addition to their acquisition cost and dispensing fee.

Other Providers

Effective January 1, 2013, an HFS enrolled provider, with the exception of a pharmacy provider, that is eligible to participate in the 340B federal Drug Pricing Program under Section 340B of the federal Public Health Services Act shall be enrolled in that program. No HFS enrolled provider that is also enrolled with DHHS as a 340B provider may exclude Medicaid covered medications from their participation in the program. An HFS enrolled provider enrolled in the 340B federal Drug Pricing Program must charge the department no more than their actual acquisition cost for the drug product.

 

Providers wishing to receive e-mail notification, when new provider information is posted by the department, may register at the following HFS Web site.

 

Questions regarding this notice may be directed to the Bureau of Comprehensive Health Services at 1-877-782-5565.

Theresa A. Eagleson, Administrator
Division of Medical Programs